Entrada Therapeutics, Inc. (TRDA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$12.26
Day's range
$13.1

Entrada Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 05/15/2026 5.07 M $64.02 M   0.00% 12.26%
5AM VENTURE MANAGEMENT, LLC 05/15/2026 4.06 M $51.19 M   0.00% 9.80%
BLACKROCK, INC. 05/13/2026 2.36 M $29.77 M   9.85% 5.70%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 2.29 M $28.87 M   9.53% 5.53%
05/15/2026 1.26 M $15.85 M   100.00% 3.04%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 1.03 M $13.06 M   -0.95% 2.50%
STEPSTONE GROUP LP 05/15/2026 761.28 K $9.61 M   0.00% 1.84%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 667.35 K $8.42 M   4.28% 1.61%
STATE STREET CORP 05/15/2026 533.80 K $6.74 M   4.92% 1.29%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 526.04 K $6.64 M   60.66% 1.27%
MILLENNIUM MANAGEMENT LLC 05/15/2026 519.36 K $6.55 M   4.35% 1.26%
05/14/2026 374.01 K $4.72 M   100.00% 0.90%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2026 333.91 K $4.21 M   -7.96% 0.81%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 333.17 K $4.20 M   7.19% 0.81%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 324.47 K $4.09 M   18.69% 0.78%
NORTHERN TRUST CORP 05/14/2026 234.99 K $2.97 M   3.84% 0.57%
05/08/2026 220.49 K $2.78 M   100.00% 0.53%
WOODLINE PARTNERS LP 05/15/2026 215.98 K $2.73 M   51.98% 0.52%
CITADEL ADVISORS LLC 05/15/2026 215.02 K $2.71 M   -26.56% 0.52%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 214.75 K $2.71 M   -2.95% 0.52%
GOLDMAN SACHS GROUP INC 05/15/2026 212.78 K $2.69 M   3.71% 0.51%
LYNX1 CAPITAL MANAGEMENT LP 05/04/2026 211.69 K $2.67 M   309.54% 0.51%
LONGAEVA PARTNERS L.P. 05/15/2026 204.98 K $2.59 M   100.00% 0.50%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 202.08 K $2.55 M   -20.01% 0.49%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 181.15 K $2.29 M   0.10% 0.44%
MORGAN STANLEY 05/15/2026 176.13 K $2.22 M   -32.32% 0.43%
NUVEEN, LLC 04/30/2026 175.65 K $2.22 M   211.34% 0.42%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 159.33 K $2.01 M   100.00% 0.39%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 156.86 K $1.98 M   100.00% 0.38%
XTX TOPCO LTD 05/15/2026 129.56 K $1.64 M   10.11% 0.31%
ROYCE & ASSOCIATES LP 05/12/2026 120.85 K $1.53 M   -51.10% 0.29%
MOORE CAPITAL MANAGEMENT, LP 05/15/2026 105.00 K $1.33 M   0.00% 0.25%
ACUTA CAPITAL PARTNERS, LLC 05/15/2026 89.36 K $1.13 M   100.00% 0.22%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 87.45 K $1.10 M   -50.32% 0.21%
TREXQUANT INVESTMENT LP 05/15/2026 82.73 K $1.04 M   -31.78% 0.20%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 79.49 K $1.00 M   202.78% 0.19%
D. E. SHAW & CO., INC. 05/15/2026 79.05 K $997.57 K   18.20% 0.19%
AMERICAN CENTURY COMPANIES INC 05/15/2026 77.97 K $983.99 K   3.57% 0.19%
BANK OF NEW YORK MELLON CORP 05/05/2026 76.43 K $964.51 K   -3.71% 0.18%
QUANTINNO CAPITAL MANAGEMENT LP 05/15/2026 71.02 K $896.25 K   4.87% 0.17%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2026 70.66 K $891.68 K   24.96% 0.17%
AMERIPRISE FINANCIAL INC 05/15/2026 70.28 K $886.93 K   -17.21% 0.17%
MARSHALL WACE, LLP 05/15/2026 53.76 K $678.50 K   160.27% 0.13%
TD ASSET MANAGEMENT INC 05/11/2026 53.59 K $676.28 K   41.81% 0.13%
NAN FUNG GROUP HOLDINGS LTD 05/14/2026 49.08 K $619.42 K   0.00% 0.12%
CANTOR FITZGERALD, L. P. 05/15/2026 47.00 K $593.14 K   -17.54% 0.11%
TWO SIGMA INVESTMENTS, LP 05/15/2026 44.60 K $562.88 K   -9.53% 0.11%
INVESCO LTD. 05/12/2026 41.93 K $529.11 K   2.18% 0.10%
MARTINGALE ASSET MANAGEMENT L P 05/13/2026 41.76 K $527.05 K   12.71% 0.10%
GREAT LAKES ADVISORS, LLC 05/12/2026 41.53 K $524.12 K   -4.01% 0.10%

Entrada Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 140 institutional investors and hedge funds held shares of Entrada Therapeutics Inc. The most heavily invested institutionals were:

BAKER BROS. ADVISORS LP: 5.07 M

5AM Venture Management, LLC: 4.06 M

BlackRock, Inc.: 2.36 M

TCG Crossover Management, LLC: 2.29 M

WELLINGTON MANAGEMENT GROUP LLP: 1.03 M

StepStone Group LP: 761,277

61.58% of Entrada Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 31.63 M shares in the last 24 months. This purchase volume represents approximately $401.76 M in transactions.